Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Bayer Pharma Aktiengesellschaft
Bayer Pharma Aktiengesellschaft xfc xdf
  

Bayer Pharma Aktiengesellschaft patents (2015 archive)

Recent patent applications related to Bayer Pharma Aktiengesellschaft. Bayer Pharma Aktiengesellschaft is listed as an Agent/Assignee. Note: Bayer Pharma Aktiengesellschaft may have other listings under different names/spellings. We're not affiliated with Bayer Pharma Aktiengesellschaft, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Bayer Pharma Aktiengesellschaft-related inventors




Date Bayer Pharma Aktiengesellschaft patents (2015 archive) (updated weekly) - BOOKMARK this page
12/31/15Amidoimidazopyridazines as mknk-1 kinase inhibitors
12/31/154-substituted pyrrolo- and pyrazolo-diazepines
12/24/15Amino-substituted isothiazoles
12/03/15Combination comprising radium-223 for the treatment of cancer
12/03/15Combination comprising radium-223 for the treatment of cancer
12/03/15Bet-protein-inhibiting dihydroxyquinoxalinones
11/26/15Formulation for bispecific t-cell engagers (bites)
11/26/15Formulation for bispecific t-cell engagers (bites)
11/26/15Lock for drug injection device
11/19/15Fusion polypeptides and uses thereof
11/05/15Patient reported outcome instruments for endometriosis
10/29/15Substituted pyrazolopyrimidines as akt kinase inhibitors
10/22/15Bet protein-inhibiting 5-aryl triazole azepines
10/15/15Aminoimidazopyridazines
10/15/155-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
10/15/154-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfoximine group
10/01/155-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
10/01/15N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
10/01/15Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
10/01/15Substituted annulated triazines and use thereof
09/24/15Biomarkers for determining effective response of treatments of hepatocellular carcinoma (hcc) patients
09/17/154-(ortho)-fluorophenyl-5-fluoropyrimidin-2-yl amines containing a sulfone group
09/10/15Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperproliferative diseases
08/27/15Substituted pyrrolopyrimidinylamino-benzothiazolones as mknk kinase inhibitors
08/27/15Substituted pyrrolopyrimidinylamino-benzothiazolones as mknk kinase inhibitors
08/20/15Catheter with drug coating
08/06/15Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperfoliferative disorders
07/30/15Substituted triazolopyridines and their use as ttk inhibitors
07/30/153-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
07/23/15Combination of regorafenib and acetylsalicylic acid for treating cancer
07/23/152,3-benzodiazepines
07/09/15N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products
07/02/15Substituted piperidines
06/25/15Substituted aminoindane- and aminotetralinecarboxylic acids and the use thereof
06/04/15N-[3-(2-carboxyethyl)phenyl]piperidin-1-ylacetamide derivatives and use thereof as activators of soluble guanylate cyclase
06/04/15Substituted benzothienopyrimidines
05/28/15Bicyclically substituted uracils and the use thereof
05/28/15Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use
05/28/15Method for preparing substituted triazolopyridines
05/28/15Bicyclically substituted uracils and the use thereof
05/28/15Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use
05/28/15Method for preparing substituted triazolopyridines
05/21/15Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer
05/14/15Bis azainositol heavy metal complexes for x-ray imaging
05/14/15Thienopyrimidines
05/14/15Substituted pyrrolopyrimidines
05/07/15Pharmaceutical administration forms comprising 5-chloro-n-(methyl)-2-thiophenecarboxamide
05/07/15(aza)pyridopyrazolopyrimidinones and indazolopyrimidinones and their use
04/30/15Application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems in the treatment of menorrhagia, as well as intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one for treating uterine bleeding disorders
04/16/15Substituted imidazopyridazines
04/09/15Antibodies capable of binding to the coagulation factor xi and/or its activated form factor xia and uses thereof
04/02/15Amino-substituted imidazopyridazines
03/19/15Substituted benzothienyl - pyrrolotriazines and uses thereof in the treatment cancer
03/19/15Phenyl and benzodioxinyl substituted indazoles derivatives
03/05/15Intrauterine application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems, intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, as well as the use thereof in contraception and gynaecological therapy
02/19/15Tyrosine based linkers for the releasable connection of peptides
01/01/15Substituted phenylimidazopyrazoles and use thereof
01/01/15Substituted imidazopyrazines as akt kinase inhibitors







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Bayer Pharma Aktiengesellschaft in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Bayer Pharma Aktiengesellschaft with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';